176 related articles for article (PubMed ID: 160714)
21. Determination of plasmin-alpha 2-antiplasmin complex in plasma samples by means of a radioimmunoassay.
Wiman B; Jacobsson L; Andersson M; Mellbring G
Scand J Clin Lab Invest; 1983 Feb; 43(1):27-33. PubMed ID: 6194554
[TBL] [Abstract][Full Text] [Related]
22. Age-related reference values for activation markers of the coagulation and fibrinolytic systems in children.
Ries M; Klinge J; Rauch R
Thromb Res; 1997 Feb; 85(4):341-4. PubMed ID: 9062957
[TBL] [Abstract][Full Text] [Related]
23. Coagulopathy in hemorrhagic fever with renal syndrome (Korean hemorrhagic fever).
Lee M; Kim BK; Kim S; Park S; Han JS; Kim ST; Lee JS
Rev Infect Dis; 1989; 11 Suppl 4():S877-83. PubMed ID: 2568677
[TBL] [Abstract][Full Text] [Related]
24. [Molecular markers of hemostatic-mechanisms--plasmin-alpha 2 plasmin inhibitor complex].
Kawai Y; Watanabe K
Rinsho Byori; 1989 Mar; 37(3):248-55. PubMed ID: 2526263
[No Abstract] [Full Text] [Related]
25. [Coagulation and fibrinolysis in pregnancy].
Yuasa S; Ishizawa M; Yuki Y; Minoura T; Fujita N; Takahashi H; Yoshimura M; Yamamoto T; Okada H
Rinsho Byori; 1992 Dec; 40(12):1287-91. PubMed ID: 1284915
[TBL] [Abstract][Full Text] [Related]
26. [Clinical significance of thrombin-antithrombin III complex and plasmin-alpha 2 plasmin inhibitor complex in chronic liver diseases].
Ohmoto K; Yamamoto S; Ideguchi S; Yamamoto R; Takatori K; Ohumi T; Hino K; Hirano Y
Nihon Shokakibyo Gakkai Zasshi; 1990 Sep; 87(9):1837-45. PubMed ID: 2147451
[TBL] [Abstract][Full Text] [Related]
27. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
Bokarev IN; Butorov VN; Loginov LE
Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
[No Abstract] [Full Text] [Related]
28. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; measurement with new synthetic substrate method].
Ujiie M; Kuroiwa K; Nagasawa T; Sato Y; Kitahara N
Rinsho Byori; 1989 Apr; Spec No 81():208-13. PubMed ID: 2754807
[No Abstract] [Full Text] [Related]
29. Plasma thrombomodulin and alpha 2-plasmin inhibitor-plasmin complex are elevated in active systemic lupus erythematosus.
Kawakami M; Kitani A; Hara M; Harigai M; Suzuki K; Kawaguchi Y; Ishii H; Kazama M; Kawagoe M; Nakamura H
J Rheumatol; 1992 Nov; 19(11):1704-9. PubMed ID: 1337109
[TBL] [Abstract][Full Text] [Related]
30. [Thrombin, antithrombin, thrombin-antithrombin complex (TAT)].
Sakata T
Nihon Rinsho; 2004 Dec; 62 Suppl 12():626-8. PubMed ID: 15658407
[No Abstract] [Full Text] [Related]
31. Antigenic changes produced by complex formation between thrombin and antithrombin-III.
McDuffie FC; Peterson JM; Clark G; Mann KG
J Immunol; 1981 Jul; 127(1):239-44. PubMed ID: 6787123
[TBL] [Abstract][Full Text] [Related]
32. [Clinical significance of plasma alpha 2-plasmin inhibitor activity in obstetrics].
Miura Y
Nihon Ika Daigaku Zasshi; 1986 Jun; 53(3):258-70. PubMed ID: 3734048
[No Abstract] [Full Text] [Related]
33. [Evaluation of the assay for alpha 2PI and alpha 2PI-plasmin complex using the one-step sandwich method (EIA)].
Aoki N; Takenaga T; Hasegawa H; Oguma Y; Kobayashi N; Sakata Y; Fujimaki M; Ikematsu S; Kuroso K; Matsuda T
Rinsho Byori; 1987 Nov; 35(11):1275-81. PubMed ID: 2965268
[No Abstract] [Full Text] [Related]
34. Time course of clotting and fibrinolytic markers in acute upper gastrointestinal bleeding: relation to diagnosis and blood transfusion treatment.
Henriksson AE; Nilsson TK; Svensson JO
Blood Coagul Fibrinolysis; 1993 Dec; 4(6):877-80. PubMed ID: 7511945
[TBL] [Abstract][Full Text] [Related]
35. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system.
Holvoet P; de Boer A; Verstreken M; Collen D
Thromb Haemost; 1986 Oct; 56(2):124-7. PubMed ID: 2433784
[TBL] [Abstract][Full Text] [Related]
36. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; alpha 2 plasmin inhibitor plasmin complex].
Itoh N
Rinsho Byori; 1989 Apr; Spec No 81():202-7. PubMed ID: 2526884
[No Abstract] [Full Text] [Related]
37. [Diagnosis of DIC based on evidence].
Wada H; Nishioka J; Nobori T; Sakaguchi A; Abe Y
Rinsho Byori; 2006 Nov; 54(11):1172-7. PubMed ID: 17240840
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity in the incidence and clinical manifestations of disseminated intravascular coagulation: a study of 204 cases.
Okajima K; Sakamoto Y; Uchiba M
Am J Hematol; 2000 Nov; 65(3):215-22. PubMed ID: 11074538
[TBL] [Abstract][Full Text] [Related]
39. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
Kaibara M; Watanabe T; Ooka F; Liang SG; Aisaka K; Okinaga S
Clin Hemorheol Microcirc; 2001; 24(2):93-9. PubMed ID: 11381184
[TBL] [Abstract][Full Text] [Related]
40. Plasminogen activation in vivo upon intravenous infusion of DDAVP. Quantitative assessment of plasmin-alpha 2-antiplasmin complex with a novel monoclonal antibody based radioimmunoassay.
Levi M; de Boer JP; Roem D; ten Cate JW; Hack CE
Thromb Haemost; 1992 Jan; 67(1):111-6. PubMed ID: 1377412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
